Kunihiro Suzuki
Nihon University(JP)
Publications by Year
Research Areas
Diabetes Treatment and Management, dental development and anomalies, Diabetes Management and Research, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease(2018)367 cited
- → Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function(2011)283 cited
- → Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes(2016)198 cited
- → Co‐administration of proton pump inhibitors delays elimination of plasma methotrexate in high‐dose methotrexate therapy(2008)159 cited
- → Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice(2017)101 cited
- → Aldosterone Impairs Vascular Endothelial Cell Function(2006)96 cited
- → Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan Public Health Center-based Prospective Study (JPHC Study)(2015)85 cited
- → Clinical Implication of Plasma Hydrogen Sulfide Levels in Japanese Patients with Type 2 Diabetes(2016)77 cited
- → FORMATION AND TURNOVER OF THE MAJOR BRAIN GANGLIOSIDES DURING DEVELOPMENT *(1967)59 cited
- → Cilostazol inhibits cytokine-induced nuclear factor- B activation via AMP-activated protein kinase activation in vascular endothelial cells(2008)58 cited